Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	CAD Financing Warrants	2022 USD Financing Warrants	Common Stock	Common Stock CAD Financing Warrants	Common Stock 2022 USD Financing Warrants	Additional Paid-In Capital	Additional Paid-In Capital CAD Financing Warrants	Additional Paid-In Capital 2022 USD Financing Warrants	Accumulated OCI	Accumulated Deficit
Balance at Dec. 31, 2021	$ 151,664						$ 288,290			$ 1,046	$ (137,672)
Balance, Shares at Dec. 31, 2021				28,126,414
Issuance of common shares and warrants, net of share issuance costs	42,297						42,297
Issuance of common shares and warrants, net of share issuance costs, Shares				9,370,476
Exercise of Financing Warrants		$ 708						$ 708
Exercise of Financing Warrants, Shares					76,021
Exercise of stock options	206						206
Exercise of stock options, Shares				38,275
Settlement of restricted share unit awards				367,950
Withholding taxes paid on vested restricted share units	(407)						(407)
Stock-based compensation expense	13,664						13,664
Net loss and Comprehensive loss	(57,215)									(419)	(56,796)
Balance at Dec. 31, 2022	150,917						344,758			627	(194,468)
Balance, Shares at Dec. 31, 2022				37,979,136
Issuance of common shares and warrants, net of share issuance costs	7,823						7,823
Issuance of common shares and warrants, net of share issuance costs, Shares				2,232,113
Exercise of Financing Warrants			$ 178						$ 178
Exercise of Financing Warrants, Shares						27,000
Exercise of stock options	$ 49						49
Exercise of stock options, Shares	13,333			13,333
Settlement of restricted share unit awards				849,721
Stock-based compensation expense	$ 15,183						15,183
Net loss and Comprehensive loss	(96,016)									(284)	(95,732)
Balance at Dec. 31, 2023	$ 78,134						$ 367,991			$ 343	$ (290,200)
Balance, Shares at Dec. 31, 2023				41,101,303